Correlation of soluble growth stimulation expressed gene 2 and galectin-3 with myocardial fibrosis in patients with coronary artery disease

Zhang Yulian; Deng Wei; Wang Yunhui; Chen Shiyu; Zheng Fang

doi:10.13406/j.cnki.cyxb.003378

您当前的位置：

首页 >

文章列表页 >

Correlation of soluble growth stimulation expressed gene 2 and galectin-3 with myocardial fibrosis in patients with coronary artery disease

Clinical research | 更新时间：2025-12-29

- Correlation of soluble growth stimulation expressed gene 2 and galectin-3 with myocardial fibrosis in patients with coronary artery disease
- Journal of Chongqing Medical University Vol. 49, Issue 1, Pages: 37-43(2024)
- 作者机构：
  
  重庆医科大学附属第二医院全科医学科，重庆 400010
- 作者简介：
- 基金信息：
- DOI：10.13406/j.cnki.cyxb.003378
  CLC： R542
- Received：29 May 2023，
  
  Revised：2023-09-27，
  
  Accepted：01 November 2023，
  
  Published：28 January 2024
- 稿件说明：
移动端阅览
张玉莲,邓玮,王云会,等.冠心病患者sST2、Gal-3水平与心肌纤维化的相关性研究[J].重庆医科大学学报,2024,49(1):37-43.

Zhang Yulian,Deng Wei,Wang Yunhui,et al.Correlation of soluble growth stimulation expressed gene 2 and galectin-3 with myocardial fibrosis in patients with coronary artery disease[J].Journal of Chongqing Medical University,2024,49(1):37-43.
张玉莲,邓玮,王云会,等.冠心病患者sST2、Gal-3水平与心肌纤维化的相关性研究[J].重庆医科大学学报,2024,49(1):37-43. DOI： 10.13406/j.cnki.cyxb.003378.

Zhang Yulian,Deng Wei,Wang Yunhui,et al.Correlation of soluble growth stimulation expressed gene 2 and galectin-3 with myocardial fibrosis in patients with coronary artery disease[J].Journal of Chongqing Medical University,2024,49(1):37-43. DOI： 10.13406/j.cnki.cyxb.003378.

摘要

目的

探讨冠心病（coronary artery disease，CAD）患者可溶性生长刺激表达基因2蛋白（soluble growth stimulation expressed gene 2，sST2）、半乳糖凝集素-3（galectin-3，Gal-3）与心肌纤维化（myocardial fibrosis，MF）的关系，指导临床缺血性MF的评估。

方法

以顺序入选2021年9月至2022年9月在重庆医科大学附属第二医院科住院的冠心病受试者56例非冠心病患者31例为研究对象，根据心血管磁共振-延迟钆增强（cardiovascular magnetic resonance-late gadolinium enhancement，CMR-LGE）将冠心病组分为心肌纤维化（LGE阳性）亚组和非心肌纤维化（LGE阴性）亚组。收集所有受试者的一般临床资料。所有受试者均通过酶联免疫吸附法测定血清sST2、Gal-3水平。分析sST2、Gal-3与CMR-LGE结果的相关性。

结果

①CAD组患者sST2、Gal-3、血压、肌酐、尿酸、室间隔厚、糖化血红蛋白、CAS评分高于非CAD组患者（

0.05），而肾小球滤过率、高密度脂蛋白低于非CAD患者（

0.05）。②LGE阳性亚组sST2、Gal-3、B型利钠肽原水平较LGE阴性亚组高（

0.05），高密度脂蛋白较LGE阴性亚组低（

0.05）。③LGE与sST2（

=0.338，

=0.011）、Gal-3（

=0.428，

=0.001）、B型利钠肽原（

=0.364，

=0.006）呈正相关，与高密度脂蛋白（

=-0.339，

=0.011）呈负相关，纳入控制变量进行偏相关分析得出LGE与sST2（

=0.312，

=0.037）、Gal-3（

=0.419，

=0.004）独立相关。④sST2、Gal-3以及两者联合检测心肌纤维化的敏感度分别是65%、87%、70%，特异度分别是81%、56%、87%，sST2、Gal-3预测有无心肌纤维化的最佳临界值分别是36.01 ng/mL、13.04 ng/mL。

结论

sST2、Gal-3可用于预测缺血性心肌纤维化，与CMR-LGE评估心肌纤维化具有高度一致性。

Abstract

Objective

To investigate the correlation of soluble growth stimulation expressed gene 2（sST2） and galectin-3（Gal-3） with myocardial fibrosis（MF） in patients with coronary artery disease（CAD），and to guide the evaluation of ischemic MF in clinical practice.

Methods

A total of 56 patients with CAD and 31 patients without CAD who were hospitalized in our department from September 2021 to September 2022 were enrolled as subjects，and according to the results of cardiovascular magnetic resonance-late gadolinium enhancement（CMR-LGE），the CAD group was further divided into MF（LGE positive） subgroup and non-MF（LGE negative） subgroup. General clinical data were collected from all subjects，and ELISA was used to measure the serum levels of sST2 and Gal-3. The correlation of sST2 and Gal-3 with CMR-LGE results was analyzed.

Results

Compared with the non-CAD group，the CAD group had significantly higher levels of sST2 and Gal-3，blood pressure，creatinine，uric acid，interventricular septum thickness，glycosylated hemoglobin，and CAS score（

0.05） and significantly lower glomerular filtration rate and high-density lipoprotein（

0.05）. Compared with the LGE-negative subgroup，the LGE-positive subgroup had significantly higher levels of sST2，Gal-3，and pro-B-type natriuretic peptide（

0.05） and a significantly lower level of high-density lipoprotein（

0.05）. LGE was positively correlated with sST2（

=0.338，

=0.011），Gal-3（

=0.428，

=0.001），and pro-B-type natriuretic peptide（

=0.364，

=0.006） and was negatively correlated with high-density lipoprotein（

=-0.339，

=0.011），and the partial correlation analysis with control variables showed that LGE was independently correlated with sST2（

=0.312，

=0.037） and Gal-3（

=0.419，

=0.004）. The analysis showed that sST2 or Gal-3 used alone or in combination had a sensitivity of 65%，87%，and 70%，respectively，and a specificity of 81%，56%，and 87%，respectively，in detecting MF，and sST2 and Gal-3 had an optimal cut-off value of 36.01 ng/mL and 13.04 ng/mL，respectively，in predicting the presence or absence of ischemic MF.

Conclusion

This study shows that sST2 and Gal-3 can be used to predict ischemic MF and are highly consistent with CMR-LGE in evaluating MF.

关键词

Keywords

references

Osokina A ， Karetnikova V ， Polikutina O ， et al . Prognostic potential of cardiac structural and functional parameters and N-terminal propeptide of type III procollagen in predicting cardiac fibrosis one year after myocardial infarction with preserved left ventricular ejection fraction [J ] . Aging ， 2021 ， 13 （ 1 ）： 194 - 203 .

Rorabaugh B ， Mabe N ， Seeley S ， et al . Myocardial fibrosis，inflammation，and altered cardiac gene expression profiles in rats exposed to a predator-based model of posttraumatic stress disorder [J ] . Stress（Amsterdam，Netherlands）， 2020 ， 23 （ 2 ）： 125 - 135 .

Gupta S ， Ge Y ， Singh A ， et al . Multimodality Imaging Assessment of Myocardial Fibrosis [J ] . JACC. Cardiovascular imaging ， 2021 ， 14 （ 12 ）： 2457 - 2469 .

Salvador D ， Gamba M ， Gonzalez-Jaramillo N ， et al . Diabetes and Myocardial Fibrosis：A Systematic Review and Meta-Analysis [J ] . JACC. Cardiovascular imaging ， 2022 ， 15 （ 5 ）： 796 - 808 .

Kanagala P ， Cheng A ， Singh A ， et al . Relationship Between Focal and Diffuse Fibrosis Assessed by CMR and Clinical Outcomes in Heart Failure With Preserved Ejection Fraction [J ] . JACC. Cardiovascular imaging ， 2019 ， 12 ： 2291 - 2301 .

Frangogiannis N . Cardiac fibrosis [J ] . Cardiovascular research ， 2021 ， 117 （ 6 ）： 1450 - 1488 .

Vértes V ， Porpáczy A ， Nógrádi Á ， et al . Galectin-3 and sST2：associations to the echocardiographic markers of the myocardial mechanics in systemic sclerosis - a pilot study [J ] . Cardiovascular ultrasound ， 2022 ， 20 （ 1 ）： 1 .

Dudek M ， Kałużna-Oleksy M ， Migaj J ， et al . sST2 and Heart Failure-Clinical Utility and Prognosis [J ] . Journal of clinical medicine ， 2023 ， 12 （ 9 ）： 3136 .

李春兰，贺延平，何瑾 . 新型生物标记物在心力衰竭患者中的研究进展 [J ] . 中国心血管病研究， 2021 ， 19 （ 12 ）： 1095 - 1098 .

Li CL ， He YP ， He J . Research progress of novel biomarkers in patients with heart failure [J ] . Chinese Journal of Cardiovascular Research ， 2021 ， 19 （ 12 ）： 1095 - 1098 .

Matilla L ， Arrieta V ， Jover E ， et al . Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1 [J ] . Cells ， 2020 ， 9 （ 7 ）： 9071667 .

Matilla L ， Ibarrola J ， Arrieta V ， et al . in vitroSoluble ST2 promotes oxidative stress and inflammation in cardiac fibroblasts：an and study in aortic stenosis [J ] . Clinical science（London ， England： 1979 ）， 2019 ， 133 （ 14 ）： 1537 - 1548 .

Ding Z ， Du W ， Lei Z ， et al . Neuropilin 1 modulates TGF‑β1‑induced epithelial‑mesenchymal transition in non‑small cell lung cancer [J ] . International journal of oncology ， 2020 ， 56 （ 2 ）： 531 - 543 .

Pratama R ， Hartopo A ， Anggrahini D ， et al . Serum soluble suppression of tumorigenicity-2 level associates with severity of pulmonary hypertension associated with uncorrected atrial septal defect [J ] . Pulmonary circulation ， 2020 ， 10 （ 2 ）： 2045894020915832 .

Geenen L ， Baggen V ， Kauling R ， et al . The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension [J ] . Journal of clinical medicine ， 2019 ， 8 （ 10 ）： 15 - 17 .

Obradovic DM ， Büttner P ， Rommel KP ， et al . Soluble ST2 Receptor：Biomarker of Left Ventricular Impairment and Functional Status in Patients with Inflammatory Cardiomyopathy [J ] . Cells ， 2022 ， 11 （ 3 ）： 11030414 .

Blanda V ， Bracale U ， Di Taranto M ， et al . Galectin-3 in Cardiovascular Diseases [J ] . International journal of molecular sciences ， 2020 ， 21 （ 23 ）： 21239232 .

Cao Z ， Yu X ， Leng P . Research progress on the role of gal-3 in cardio/cerebrovascular diseases [J ] . Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie ， 2021 ， 133 ： 111066 .

Ureche C ， Dodi G ， Covic A ， et al . Connection between Cardiac Fibrosis Biomarkers and Echocardiography Parameters in Advanced Chronic Kidney Disease Patients [J ] . Journal of clinical medicine ， 2023 ， 12 （ 8 ）： 3003 .

王彦玲，王燕庆，刘东霞，等 . 半乳糖凝集素3在心血管疾病中的研究进展 [J ] . 中华老年心脑血管病杂志， 2021 ， 23 （ 11 ）： 1221 - 1223 .

Wang YL ， Wang YQ ， Liu DX ， et al . Research progress of Galectin-3 in cardiovascular diseases [J ] . Chinese Journal of Geriatric Heart Brain and Vessel Diseases ， 2021 ， 23 （ 11 ）： 1221 - 1223 .

Hara A ， Niwa M ， Kanayama T ， et al . Galectin-3：A Potential Prognostic and Diagnostic Marker for Heart Disease and Detection of Early Stage Pathology [J ] . Biomolecules ， 2020 ， 10 （ 9 ）： 1277 .

Lyngbakken M ， Myhre P ， Røsjø H ， et al . Novel biomarkers of cardiovascular disease：Applications in clinical practice [J ] . Critical reviews in clinical laboratory sciences ， 2019 ， 56 （ 1 ）： 33 - 60 .

Zhong X ， Qian X ， Chen G ， et al . The role of galectin-3 in heart failure and cardiovascular disease [J ] . Clinical and experimental pharmacology & physiology ， 2019 ， 46 （ 3 ）： 197 - 203 .

Sun Z ， Zhang L ， Li L ， et al . Galectin-3 mediates cardiac remodeling caused by impaired glucose and lipid metabolism through inhibiting two pathways of activating Akt [J ] . American journal of physiology. Heart and circulatory physiology ， 2021 ， 320 （ 1 ）： H364 - H380 .

Li S ， Li S ， Hao X ， et al . Perindopril and a Galectin-3 Inhibitor Improve Ischemic Heart Failure in Rabbits by Reducing Gal-3 Expression and Myocardial Fibrosis [J ] . Frontiers in physiology ， 2019 ， 10 ： 267 .

Akin S ， Kubat G ， Guray U ， et al . Possible value of galectin-3 on follow-up of cardiac remodeling during glucocorticoid treatment [J ] . Journal of biochemical and molecular toxicology ， 2021 ， 35 （ 4 ）： e22717 .

Aksan G ， Gedikli Ö ， Keskin K ， et al . Is galectin-3 a biomarker，a player-or both-in the presence of coronary atherosclerosis? [J ] . Journal of investigative medicine：the official publication of the American Federation for Clinical Research ， 2016 ， 64 （ 3 ）： 764 - 770 .

Szadkowska I ， Wlazeł R ， Migała M ， et al . The association between galectin-3 and clinical parameters in patients with first acute myocardial infarction treated with primary percutaneous coronary angioplasty [J ] . Cardiology journal ， 2013 ， 20 （ 6 ）： 577 - 582 .

Yakar Tülüce S ， Tülüce K ， Çil Z ， et al . Galectin-3 levels in patients with hypertrophic cardiomyopathy and its relationship with left ventricular mass index and function [J ] . Anatolian journal of cardiology ， 2016 ， 16 （ 5 ）： 344 - 348 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Research advances in programmed cell death mechanisms underlying myocardial fibrosis

Regulatory effect of transcription factor E4BP4 on pathological myocardial fibrosis through the AMPK-TGF-β1/SMAD3 signaling pathway

Anacardic acid attenuates myocardial fibrosis through inhibiting histone H4K16ac hyperacetylation mediated by KAT8 in TAC mice

Correlation between the ascending aortic elasticity evaluated by speckle tracking imaging and the coronary artery lesion of patients with coronary heart disease

Correlation between Galectin-3 and Wnt pathway-related protein in salivary gland tumor

Related Author

Ma Wenxiu

Ma Wen

Bai Li

Zhang Xin

Qi Tingting

Wen Qing

Su Yuchen

Huang Derong

Related Institution

Baotou Medical College， Inner Mongolia University of Science and Technology

Department of Cardiology， The First Affiliated Hospital of Baotou Medical College，Inner Mongolia University of Science and Technology

The Central Lab，The First Affiliated Hospital of Baotou Medical College，Inner Mongolia University of Science and Technology

Department of Cardiovascular Surgery，Affiliated Hospital of Zunyi Medical University

Department of Pediatrics，Guizhou Children's Hospital/The Affiliated Hospital of Zunyi Medical University

⁰